News

Nutriband Inc. Receives Notice of Allowance from Korean Intellectual Property Office (KIPO) for its ‘Abuse and Misuse Deterrent Transdermal System’ Patent

ORLANDO, Fla., Dec. 10, 2020 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”) has received a notice of allowance from the Korean Intellectual Property Office (KIPO) for the ‘Abuse and Misuse Deterrent Transdermal Systems’ patent application filed by its clinical subsidiary 4P Therapeutics. The patent underpins 4p Therapeutics’ abuse deterrent fentanyl transdermal system, AVERSA, which uses Taste aversion …

Nutriband Inc. Receives Notice of Allowance from Korean Intellectual Property Office (KIPO) for its ‘Abuse and Misuse Deterrent Transdermal System’ Patent Read More »

Nutriband Inc. Signs Exclusive Distribution Agreement With Oran Textiles for Cifra Reusable V-Block Coated Facemasks

ORLANDO, Fla., Sept. 15, 2020 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), announced that it has agreed terms with Irish based Oran Textiles Ltd. for the US and Korean distribution rights for Oran Textiles V-block coated facemasks.  The masks, are a marriage of Italian based Cifra’s Warpmask technology with HEIQ V-Block (Viroblock) technology. HeiQ’s V-Block technology shown strong antimicrobial efficacy …

Nutriband Inc. Signs Exclusive Distribution Agreement With Oran Textiles for Cifra Reusable V-Block Coated Facemasks Read More »

Nutriband Inc. Completes Acquisition of Transdermal Manufacturing Business for $7.5 Million

ORLANDO, Fla., Sept. 2, 2020 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation, announced that it has completed the acquisition of Pocono Coated Product’s Transdermal and Health product manufacturing business effective August 31, 2020. Pocono Coated Products was established in 2004 with a focus on the manufacturing of custom coated products and providing manufacturing and development services for 3rd party …

Nutriband Inc. Completes Acquisition of Transdermal Manufacturing Business for $7.5 Million Read More »

Nutriband’s AVERSA Trademark Application Receives No Opposition

ORLANDO, Fla., July 22, 2020 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation has announced that the application for its ‘AVERSA’ Trademark in relation to its abuse deterrent technology and lead product candidate has passed the examination and third party opposition phase and the company expects to receive a notice of allowance in due time. Previously named Defent, AVERSA™ …

Nutriband’s AVERSA Trademark Application Receives No Opposition Read More »

conference room, table, office

Nutriband Inc. and Pocono Coated Products Agree Terms on Acquisition

ORLANDO, Fla., July 16, 2020 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada Corporation, announced that it has agreed terms for the acquisition of Pocono Coated Product’s Transdermal and Health product manufacturing Business. The acquisition is another step in our expansion plans to strengthen the company, following our acquisition of 4P Therapeutics. Pocono is set to become the manufacturing …

Nutriband Inc. and Pocono Coated Products Agree Terms on Acquisition Read More »

Nutriband Inc. Receives Patent Protection from Australia, Russia and Mexico

ORLANDO, Fla., March 18, 2020 /PRNewswire/ —  Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”) has received a notice of grant from patent offices in Australia and Russia and a notice of allowance from Mexico’s patent office for the ‘Abuse and Misuse Deterrent Transdermal Systems’ patent application filed by its clinical subsidiary 4P Therapeutics The patent underpins 4P Therapeutics’ abuse deterrent fentanyl transdermal system, which uses taste aversion …

Nutriband Inc. Receives Patent Protection from Australia, Russia and Mexico Read More »

Nutriband Financials

Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by Japan’s Patent Office

ORLANDO, Fla., April 23, 2019 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”), announced today that the Japan Patent Office has granted full patent protection for Japanese Patent Application entitled, “Abuse and Misuse Deterrent Transdermal System” submitted by its subsidiary, 4P Therapeutics.  The patent relates to the Company’s proprietary abuse deterrent transdermal technology, utilized in the fentanyl transdermal system …

Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by Japan’s Patent Office Read More »

Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by European Patent Office

ORLANDO, Fla., March 26, 2019 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the “Company”), announced today that the European Patent Office has granted full patent protection for European Patent Application EP15740893.1 entitled, “Abuse and Misuse Deterrent Transdermal System” submitted by its subsidiary, 4P Therapeutics.  The patent relates to the Company’s proprietary abuse deterrent transdermal technology, utilized in the fentanyl transdermal …

Nutriband Inc.’s Abuse Deterrent Transdermal Technology Patent Granted by European Patent Office Read More »

Nutriband Inc. Granted Prioritized Examination from the United States Patent and Trademark Office for Abuse Deterrent Technology Patent Application

ORLANDO, Fla., Jan. 29, 2019 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a Nevada corporation, announced today that the United States Patent and Trademark Office (“USPTO”) has granted the Company’s request for Prioritized Examination (Track One) of the U.S. patent application for “Abuse and Misuse Deterrent Transdermal System” submitted by its subsidiary, 4P Therapeutics LLC. Track One gives the Company’s application …

Nutriband Inc. Granted Prioritized Examination from the United States Patent and Trademark Office for Abuse Deterrent Technology Patent Application Read More »

WATCH:Nutriband Inc Featured on Worldwide Business with Kathy Ireland®

ORLANDO, Fla., Oct. 18, 2018 /PRNewswire/ — Nutriband Inc. (OTCQB: NTRB), a pharmaceutical company developing and commercializing a portfolio of prescription pharmaceuticals, OTC’s and consumer products based around the science of transdermal/topical technologies, is pleased to announce the television broadcast of an exclusive interview of its CEO, Gareth Sheridan, and President, Sean Gallagher, on the weekly business television program – Worldwide Business …

WATCH:Nutriband Inc Featured on Worldwide Business with Kathy Ireland® Read More »